Crossmark

Suppression of NRAS-mutant melanoma growth with NRAS-targeting Antisense Oligonucleotide treatment reveals therapeutically relevant kinase co-dependencies

Crossref DOI link: https://doi.org/10.1038/s43856-025-00932-5

Published Online: 2025-06-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Feichtenschlager, Valentin https://orcid.org/0000-0002-3263-9285
Zheng, Yixuan James

Qu, Tiange

Hohlova, Dasha

Callanan, Ciara

Chen, Linan

Chen, Christopher

Ho, Wilson

Lee, Albert

Hwang, Yeonjoo https://orcid.org/0000-0002-3000-4710
Courtright, Arowyn

Nguyen, Thy

Marsicovetere, Olivia

Muñoz, Denise P.

Rappersberger, Klemens

Coppe, Jean-Philippe

Ortiz-Urda, Susana
Funding

Funding for this research was provided by:

American Skin Association (ASA), Verein zur Förderung der Dermatologischen Forschung (VFDF), Impact Melanoma, Outrun the Sun
License Information

Text and Data Mining valid from 2025-06-05

Version of Record valid from 2025-06-05
More Information

Article History

Received: 13 May 2024

Accepted: 23 May 2025

First Online: 5 June 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below